TechTarsFinancial Intelligence

Navigate

Browse & analyze

Why Nifty, Sensex & S&P moved

SIP, EMI, FD & more

Your saved stocks

Account

Disclaimer: TechTars provides educational analytics and financial tools for informational purposes only. Nothing on this platform constitutes investment advice, financial advice, or trading recommendations. TechTars is not a SEBI-registered investment adviser or research analyst, and no content here is a recommendation to buy, sell, or hold any security. Always consult a qualified, SEBI-registered financial advisor before making investment decisions.

TechTars

Structured financial intelligence.
No tips. No noise. Just data.

Product

Indian Stocks
US Stocks
Market Indices
SIP Calculator
Blog & Guides

Legal

Privacy Policy
Terms of Service
Disclaimer

🔒Your data stays private

© 2026 TechTars.com

Market data delayed by ~15 minutes. Not investment advice.

Home
/
US Stocks
/
Pfizer Inc. vs Merck & Co.

Pfizer Inc. vs Merck & Co.

Side-by-side stock comparison - today's price, technicals, and structured verdict.

More US stock comparisons

→Apple Inc. vs Microsoft Corporation →Microsoft Corporation vs Alphabet Inc.→Alphabet Inc. vs Meta Platforms Inc.→NVIDIA Corporation vs Advanced Micro Devices →Advanced Micro Devices vs Intel Corporation →NVIDIA Corporation vs Intel Corporation

Written by Yadav Patle· Founder, TechTars · 7+ years tracking Indian & US markets

•

Last updated: 31 July 2026 at 6:44 am IST

•How we analyse stocksFounder, TechTars · 7+ years tracking Indian & US markets

Pfizer Inc. (PFE) is down 0.95% while Merck & Co. (MRK) is down 0.44% on the NYSE/NASDAQ. Today, Merck & Co. is outperforming on a percentage basis.

$24.91

-0.95%

VS

$129.79

-0.44%

Pfizer Inc. vs Merck & Co.: today's numbers

$24.91

Price

$129.79

-0.95%

Today

-0.44%

57/100Moderate

TechTars Score

44/100Developing

Neutral

Market bias

Neutral

Neutral

Sentiment

Neutral

51 (neutral)

RSI

58 (neutral)

Downtrend

Trend

Uptrend

-

MACD

-

$24.54

Support

$127.65

$25.35

Resistance

$134.12

Medium

Confidence

Medium

Why Pfizer Inc. moved today

PFE fell 0.95% coinciding with pharma sector decline of 2.74%.

Why Merck & Co. moved today

MRK fell 0.44% coinciding with cautious outlook ahead of Q2 earnings

Read full Pfizer Inc. analysis Read full Merck & Co. analysis

This side-by-side comparison of PFE and MRK is generated from publicly available price, volume, and news data using the methodology at /methodology/stock-analysis. It is educational context, not a recommendation to buy or sell either stock, and does not say which is a "better" investment. Prices and indicators change minute-to-minute. Consult a SEBI-registered investment adviser before acting on any of this information.